earnings

Drugmaker GSK sees sales rise thanks to new products
Drugmaker GSK sees sales rise thanks to new products
Yahoo/AP
GSK
earnings
Flag link:
Biogen (BIIB) Tops Q3 Earnings & Sales, Spinraza Sales Up
Biogen (BIIB) Tops Q3 Earnings & Sales, Spinraza Sales Up
Yahoo/Zacks.com
Biogen
earnings
Flag link:
Eyes on Alcon as Novartis notches modest growth
Eyes on Alcon as Novartis notches modest growth
Biopharma Dive
Novartis
earnings
Alcon
Flag link:
Eli Lilly (LLY) Tops Q3 Earnings & Sales, Ups 2017 View
Eli Lilly (LLY) Tops Q3 Earnings & Sales, Ups 2017 View
Yahoo/Zacks.com
earnings
Eli Lilly
Flag link:
Good quarter for Roche, but competition by biosimilars concerns investors
Good quarter for Roche, but competition by biosimilars concerns investors
GoinPharma
Roche
earnings
biosimilars
Rituxan
Flag link:
3 Things You Should Expect in Gilead Sciences' Q3 Results
3 Things You Should Expect in Gilead Sciences' Q3 Results
Motley Fool
Gilead Sciences
earnings
Flag link:
Key Predictions for Q3 Earnings Reports of LLY, BIIB, NVS
Key Predictions for Q3 Earnings Reports of LLY, BIIB, NVS
Yahoo/Zacks.com
earnings
Eli Lilly
Biogen
Novartis
Flag link:
What's next for biopharma Q3 earnings
What's next for biopharma Q3 earnings
Biopharma Dive
earnings
Amgen
Bristol-Myers Squibb
Celgene
GSK
Gilead Sciences
AbbVie
Merck
Shire
Flag link:
Intuitive Surgical shares rise on Street-topping Q3 earnings
Intuitive Surgical shares rise on Street-topping Q3 earnings
The Robot Report
Intuitive Surgical
earnings
robotic surgery
Flag link:
Roche feeling first effects of biosimilar Rituxan
Roche feeling first effects of biosimilar Rituxan
Biopharma Dive
Roche
biosimilars
Rituxan
earnings
Flag link:
3 Things to Expect in Illumina's Q3 Earnings Results
3 Things to Expect in Illumina's Q3 Earnings Results
Motley Fool
Illumina
earnings
Flag link:
Abbott ticks up as Q3 tops Wall Street’s forecast
Abbott ticks up as Q3 tops Wall Street’s forecast
Mass Device
Abbott Labs
earnings
devices
Flag link:
New cancer drugs help J&J top profit estimates
New cancer drugs help J&J top profit estimates
Yahoo/Reuters
JNJ
earnings
Flag link:
Johnson & Johnson earnings: All eyes on hurricane impact
Johnson & Johnson earnings: All eyes on hurricane impact
Marketwatch
JNJ
earnings
hurricanes
Flag link:
Corrected: What Q3 earnings will look like for 5 pharma giants
Corrected: What Q3 earnings will look like for 5 pharma giants
Biopharma Dive
earnings
JNJ
Roche
Biogen
Eli Lilly
Novartis
Flag link:
2 Big Reasons Exelixis, Inc. Added $626 Million to Its Market Cap in August
2 Big Reasons Exelixis, Inc. Added $626 Million to Its Market Cap in August
Motley Fool
Exelixis
earnings
Cabometyx
Flag link:
A Perfect Storm Cut Teva Pharmaceutical Industries's Stock in Half in August
A Perfect Storm Cut Teva Pharmaceutical Industries's Stock in Half in August
Motley Fool
Teva Pharmaceutical
earnings
Flag link:
Medtronic logs fiscal Q1 earnings beat, but sales miss the mark
Medtronic logs fiscal Q1 earnings beat, but sales miss the mark
Mass Device
Medtronic
devices
earnings
Flag link:
Tesaro's Zejula rolls to No. 1 PARP position with big Q2
Tesaro's Zejula rolls to No. 1 PARP position with big Q2
Fierce Pharma
Tesaro
Zejula
PARP inhibitors
earnings
Flag link:
BioDelivery Sciences beats Q2 rev estimates, misses on EPS
BioDelivery Sciences beats Q2 rev estimates, misses on EPS
Drug Delivery Business News
BioDelivery Sciences
earnings
Flag link:

Pages